Phase I/II study of erlotinib plus S-1 for patients with previously treated non-small cell lung cancer: Thoracic Oncology Research Group (TORG) 0808/0913

  • Yoshiro Nakahara
  • , Tsuneo Shimokawa
  • , Yuki Misumi
  • , Naoyuki Nogami
  • , Tetsu Shinkai
  • , Nobuhiko Seki
  • , Yukio Hosomi
  • , Naoya Hida
  • , Hiroaki Okamoto

Research output: Contribution to journal › Article › peer-review

2 Scopus citations

Fingerprint

Dive into the research topics of 'Phase I/II study of erlotinib plus S-1 for patients with previously treated non-small cell lung cancer: Thoracic Oncology Research Group (TORG) 0808/0913'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science